Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Clin Microbiol Infect ; 26(2): 227-234, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31238116

ABSTRACT

OBJECTIVES: The role of Pseudomonas aeruginosa in the long-term prognosis of chronic obstructive pulmonary disease (COPD) is unknown. The purpose of this study was to determine whether P. aeruginosa is associated with increased risk of exacerbations or death in patients with COPD. METHODS: This is a multiregional epidemiological study based on complete data on COPD outpatients between 1 January 2010 and 31 October 2017 and corresponding microbiology and national register data. Time-dependent Cox proportional hazards models and propensity matching was used to estimate hospitalization-demanding exacerbations and death after 2 years, separately and in combination. RESULTS: A total of 22 053 COPD outpatients were followed for a median of 1082 days (interquartile-range: 427-1862). P. aeruginosa was present in 905 (4.1%) patients. During 730 days of follow-up, P. aeruginosa strongly and independently predicted an increased risk of hospitalization for exacerbation or all-cause death (HR 2.8, 95%CI 2.2-3.6; p <0.0001) and all-cause death (HR 2.7, 95%CI 2.3-3.4; p <0.0001) in analyses adjusted for known and suspected confounders. The signal remained unchanged in unadjusted analyses as well as propensity-matched subgroup analyses. Among patients 'ever colonized' with P. aeruginosa, the incidence of hospital-demanding exacerbations doubled after the time of the first colonization. CONCLUSIONS: COPD patients in whom P. aeruginosa can be cultured from the airways had a markedly increased risk of exacerbations and death. It is still not clear whether this risk can be reduced by offering patients targeted antipseudomonal antibiotics. A randomized trial is currently recruiting patients to clarify this (ClinicalTrials.gov: NCT03262142).


Subject(s)
Pseudomonas Infections/mortality , Pulmonary Disease, Chronic Obstructive/microbiology , Pulmonary Disease, Chronic Obstructive/mortality , Aged , Disease Progression , Female , Follow-Up Studies , Hospitalization/statistics & numerical data , Humans , Male , Middle Aged , Outpatients/statistics & numerical data , Proportional Hazards Models , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa , Randomized Controlled Trials as Topic , Respiratory System/microbiology , Risk Factors , Symptom Flare Up
3.
Euro Surveill ; 17(5)2012 Feb 02.
Article in English | MEDLINE | ID: mdl-22321137

ABSTRACT

Denmark experienced two waves of Mycoplasma pneumoniae infection during autumn and early winter in 2010 and 2011, respectively. Both affected the whole country. The proportion of positive results was almost the same for both, indicating that the two waves were probably of equal size. High macrolide consumption during the epidemics did not seem to affect levels of macrolide resistance in M. pneumoniae, which remain low in Demark (1% to 3%).


Subject(s)
Epidemics/statistics & numerical data , Mycoplasma pneumoniae/isolation & purification , Pneumonia, Mycoplasma/epidemiology , Anti-Bacterial Agents/therapeutic use , Denmark/epidemiology , Drug Resistance, Bacterial , Drug Utilization/statistics & numerical data , Humans , Incidence , Macrolides/therapeutic use , Mycoplasma pneumoniae/drug effects , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/drug therapy , Population Surveillance
4.
Clin Microbiol Infect ; 17(1): 50-2, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20184622

ABSTRACT

An outbreak of listeriosis in Denmark occurred in May 2009. Multilocus variable number of tandem repeats analysis typing, later confirmed by pulsed-field gel electrophoresis typing, showed that isolates from eight patients had identical patterns and were distinguishable from Listeria monocytogenes isolates from other Danish patients. Seven out of eight patients had received a meal with beef from the same meals-on-wheels delivery catering company 3 weeks prior to onset of disease. Two patients died of their infection. Large-scale delivery of precooked meals to a vulnerable population represents a threat if proper measures against listeriosis are not taken.


Subject(s)
Disease Outbreaks , Food Microbiology , Food Services , Foodborne Diseases/epidemiology , Listeriosis/epidemiology , Meat/microbiology , Adult , Aged , Aged, 80 and over , Denmark , Electrophoresis, Gel, Pulsed-Field , Female , Foodborne Diseases/diagnosis , Foodborne Diseases/mortality , Humans , Listeria monocytogenes/physiology , Listeriosis/diagnosis , Listeriosis/mortality , Male , Middle Aged
5.
HIV Med ; 10(2): 65-71, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19018878

ABSTRACT

OBJECTIVE: To investigate the impact of HIV co-infection on mortality in patients infected with hepatitis C virus (HCV). METHODS: From a nationwide Danish database of HCV-infected patients, we identified individuals diagnosed with HCV subsequent to an HIV diagnosis. For each co-infected patient, four control HCV patients without HIV were matched on age, gender and year of HCV diagnosis. Data on comorbidity, drug abuse, alcoholism and date of death were extracted from two healthcare databases. We constructed Kaplan-Meier curves and used Cox regression analyses to estimate mortality rate ratios (MRRs), controlling for comorbidity. RESULTS: We identified 483 HCV-HIV co-infected and 1932 HCV mono-infected patients, yielding 2192 and 9894 person-years of observation with 129 and 271 deaths, respectively. The 5-year probability of survival was 0.74 [95% confidence interval (CI) 0.69-0.80] for HCV-HIV co-infected patients and 0.87 (95% CI 0.85-0.89) for HCV mono-infected patients. Co-infection was associated with substantially increased mortality (MRR 2.1, 95% CI 1.7-2.6). However, prior to the first observed decrease in CD4 counts to below 300 cells/muL, HIV infection did not increase mortality in HCV-infected patients (MRR 0.9, 95% CI 0.5-1.50). CONCLUSIONS: HIV infection has a substantial impact on mortality among HCV-infected individuals, mainly because of HIV-induced immunodeficiency.


Subject(s)
AIDS-Related Opportunistic Infections/mortality , HIV-1 , Hepatitis C, Chronic/mortality , Adult , Cohort Studies , Female , Humans , Male , Prognosis , Survival Analysis
6.
Clin Microbiol Infect ; 10(8): 709-17, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15301673

ABSTRACT

Episodes of adult bacterial meningitis (ABM) at a Danish hospital in 1991-2000 were identified from the databases of the Department of Clinical Microbiology, and compared with data from the Danish National Patient Register and the Danish National Notification System. Reduced penicillin susceptibility occurred in 21 (23%) of 92 cases of known aetiology, compared to an estimated 6% in nationally notified cases (p < 0.001). Ceftriaxone plus penicillin as empirical treatment was appropriate in 97% of ABM cases in the study population, and in 99.6% of nationally notified cases. The notification rate was 75% for penicillin-susceptible episodes, and 24% for penicillin-non-susceptible episodes (p < 0.001). Cases involving staphylococci, Pseudomonas spp. and Enterobacteriaceae were under-reported. Among 51 ABM cases with no identified risk factors, nine of 11 cases with penicillin-non-susceptible bacteria were community-acquired. Severe sequelae correlated independently with age, penicillin non-susceptibility, mechanical ventilation and non-transferral to a tertiary hospital (p < 0.05; logistic regression). Other factors that correlated with severe sequelae by univariate analysis only were inappropriate clinical handling, abnormal consciousness, convulsions and nosocomial infection. Overall, the data indicated that neither age alone, community-acquired infection nor absence of identified risk factors can predict susceptibility to penicillin accurately. Recommendations for empirical antibiotic treatment for ABM should not be based exclusively on clinical notification systems with possible unbalanced under-reporting.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Ceftriaxone/pharmacology , Meningitis, Bacterial , Penicillins/pharmacology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bacteria/classification , Ceftriaxone/therapeutic use , Female , Humans , Male , Meningitis, Bacterial/drug therapy , Meningitis, Bacterial/microbiology , Meningitis, Bacterial/physiopathology , Microbial Sensitivity Tests , Middle Aged , Penicillin Resistance , Penicillins/therapeutic use , Prognosis , Risk Factors
7.
Eur J Clin Microbiol Infect Dis ; 21(10): 722-8, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12415471

ABSTRACT

The utility of amplified fragment length polymorphism (AFLP) analysis as a genotyping method for the epidemiological typing of Legionella pneumophila serogroup 1 has been previously demonstrated. This study (i). reports recommendations for the designation of the European Working Group on Legionella Infections (EWGLI) AFLP types, (ii). describes the EWGLI AFLP types identified for the 130 strains in the EWGLI culture collection, and (iii). reports the results of a newly introduced international programme of proficiency testing. Following preliminary analysis of 20 epidemiologically unrelated isolates, 16 major AFLP types were identified. A coded proficiency panel, comprising 12 additional isolates representing 9 of these 16 AFLP types, was sent to 17 centres in 14 European countries where it was analysed following a previously determined standard protocol. The identity of each coded strain (recorded as AFLP type 001-016 or untypeable) was determined by participants with reference to these 16 AFLP types, either visually or using gel analysis software where available, and reported to the coordinating centre. Nine of the 12 strains, including an epidemiologically related pair and two pairs of unrelated isolates of the same type, were correctly identified to the correct AFLP type by all or all but one of the participants. Seven laboratories correctly identified all 12 isolates, and a further seven laboratories correctly identified 11. Type identification scores ranged from 75% (1 centre), 83% (2 centres), and 92% (7 centres) to 100% (7 centres). The AFLP method as described is robust and rapid and allows the genotypic comparison of isolates of Legionella pneumophila between different testing centres without the need for exchange of the strains studied.


Subject(s)
Genes, Bacterial/genetics , Genotype , Legionella pneumophila/classification , Legionella pneumophila/genetics , Legionnaires' Disease/diagnosis , Bacterial Typing Techniques , Cohort Studies , DNA, Bacterial/analysis , Electrophoresis, Gel, Pulsed-Field , Europe/epidemiology , Female , Humans , Legionnaires' Disease/epidemiology , Male , Polymorphism, Restriction Fragment Length , Sensitivity and Specificity , Serotyping
10.
Eur J Clin Microbiol Infect Dis ; 19(10): 773-80, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11117642

ABSTRACT

The aims of this work were to assess (i) the intercentre reproducibility and epidemiological concordance of amplified fragment length polymorphism analysis for epidemiological typing of Legionella pneumophila serogroup 1, and (ii) the suitability of the method for standardisation and implementation by members of the European Working Group on Legionella Infections. Fifty coded isolates comprising two panels of well-characterised strains, a "reproducibility" panel (n=20) and an "epidemiologically related" panel (n=30), were sent to 13 centres in 12 European countries. Analysis was undertaken in each centre following a previously determined standard protocol. Results were analysed by the participants, using gel analysis software where available, and submitted to the coordinating centre. The coordinating centre reanalysed all results visually and selected data-sets with gel analysis software. Data analysis by participants yielded reproducibility (R) values of 0.20-1.00 and epidemiological concordance (E) values of 0.11-1.00, with 6 to 34 types. Following visual analysis by the coordinating centre, R=0.78-1.00, and E=0.67-1.00, with 10-20 types. Analysis of three data-sets by the coordinating centre using gel analysis software yielded R=1.00 and E=1.00, with 12, 13 or 14 types. This method can be used as a simple, rapid screening tool for epidemiological typing of isolates of Legionella pneumophila serogroup 1. Results demonstrate that the method can be highly reproducible (R=1.00) and epidemiologically concordant (E=1.00), with good discrimination. The electropherograms generated are amenable to computer-aided analysis, but strict adherence to a previously defined laboratory protocol is required. Following designation of representative type strains and patterns, this method will be adopted by the European Working Group on Legionella Infections as the first internationally standardised typing method for use in the investigation of travel-associated Legionella infections.


Subject(s)
Legionella pneumophila/classification , Polymorphism, Genetic , DNA, Bacterial/analysis , Europe/epidemiology , Genotype , Humans , Legionella pneumophila/genetics , Legionella pneumophila/immunology , Legionnaires' Disease/epidemiology , Legionnaires' Disease/microbiology , Multicenter Studies as Topic , Polymorphism, Restriction Fragment Length , Reproducibility of Results , Serotyping
11.
Antimicrob Agents Chemother ; 44(10): 2679-83, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10991843

ABSTRACT

Rifampin in combination with erythromycin is a recommended treatment for severe cases of legionellosis. Mutations in the rpoB gene are known to cause rifampin resistance in Escherichia coli and Mycobacterium tuberculosis, and the purpose of the present study was to investigate a possible similar resistance mechanism within the members of the family Legionellaceae. Since the RNA polymerase genes of this genus have never been characterized, the DNA sequence of the Legionella pneumophila rpoB gene was determined by the Vectorette technique for genome walking. A 4,647-bp DNA sequence that contained the open reading frame (ORF) of the rpoB gene (4,104 bp) and an ORF of 384 bp representing part of the rpoC gene was obtained. A 316-bp DNA fragment in the center of the L. pneumophila rpoB gene, corresponding to a previously described site for mutations leading to rifampin resistance in M. tuberculosis, was sequenced from 18 rifampin-resistant Legionella isolates representing four species (L. bozemanii, L. longbeachae, L. micdadei, and L. pneumophila), and the sequences were compared to the sequences of the fragments from the parent (rifampin-sensitive) strains. Six single-base mutations which led to amino acid substitutions at five different positions were identified. A single strain did not contain any mutations in the 316-bp fragment. This study represents the characterization of a hitherto undescribed resistance mechanism within the family Legionellaceae.


Subject(s)
Antibiotics, Antitubercular/pharmacology , Legionella pneumophila/genetics , Legionellaceae/drug effects , Mutation/genetics , Plant Proteins/genetics , Rifampin/pharmacology , Amino Acid Sequence , Base Sequence , Blotting, Southern , DNA, Bacterial/analysis , DNA, Bacterial/genetics , DNA-Directed RNA Polymerases , Drug Resistance, Microbial , Molecular Sequence Data , Reverse Transcriptase Polymerase Chain Reaction
12.
Diagn Microbiol Infect Dis ; 36(1): 43-8, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10744366

ABSTRACT

The minimal inhibitory concentration (MIC) values of erythromycin, ciprofloxacin, ofloxacin, rifampicin, and clindamycin were determined for 56 strains of Legionella pneumophila (38 patient, 3 environmental, and 15 reference strains) and 37 strains of other Legionella species (7 patient, 2 environmental, and 28 reference strains) using the epsilon-test system on BCYEalpha agar plates. High-level resistance (MIC > or = 4 microg/mL) was found only for clindamycin (57%), with MIC values ranging from 0.25-32 microg/mL. Low-level resistance was found for erythromycin (18%) (0.5 < MIC < 8), ciprofloxacin (1%) (1 < MIC < 4), and clindamycin (40%) (0.5 < MIC < 4), but not for ofloxacin and rifampicin. MIC50 for the 45 Danish clinical Legionella strains were 0.25 microg/mL (erythromycin), 0.25 microg/mL (ciprofloxacin), 0.19 microg/mL (ofloxacin), below 0.016 microg/mL (rifampicin), and 4 microg/mL (clindamycin). Of the clinical isolates, 64% were resistant to clindamycin. There were no significant differences between the MIC50 values obtained for clinical and nonclinical Legionella strains. Selected susceptible strains were exposed to increasing concentrations of either erythromycin, ciprofloxacin, or rifampicin to select for resistance. Isolates resistant to erythromycin (MIC 0.75-32 microg/mL) or ciprofloxacin (MIC 2-3 microg/mL) could be selected by a two-step procedure. One single strain recovered from media containing 50 microg/mL of erythromycin had an MIC value higher than 256 microg/mL to erythromycin. In contrast, high-level resistance toward rifampicin with MIC > or = 256 microg/mL developed as a one-step phenomenon in several strains.


Subject(s)
Ciprofloxacin/pharmacology , Drug Resistance, Multiple/physiology , Erythromycin/pharmacology , Legionella/classification , Legionella/drug effects , Rifampin/pharmacology , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Antibiotics, Antitubercular/pharmacology , Humans , Microbial Sensitivity Tests , Reproducibility of Results , Sensitivity and Specificity , Species Specificity
13.
Ugeskr Laeger ; 160(34): 4860-3, 1998 Aug 17.
Article in Danish | MEDLINE | ID: mdl-9741251

ABSTRACT

Dog bites may result in serious bacterial infections with e.g. the gram-negative rods Capnocytophaga canimorsus and Pasteurella multocida. Human disease caused by these microorganisms can be complicated by acute development of septicaemia and/or meningitis followed by disseminated intravascular coagulation syndrome, peripheral gangrene and renal failure. The mortality of C. canimorsus septicaemia is about 23-31%. These severe infections are most often reported in immunocompromised patients and occur a few days after the bite. By reviewing the literature it is concluded that the broadest prophylactic coverage is obtained by amoxicillin/clavulanic acid and that antibiotic prophylaxis should be given to all immunocompromised patients experiencing a dog bite. Moreover, prophylactic treatment should be initiated for all patients with greater penetrating wounds and those involving the hands.


Subject(s)
Bacterial Infections/transmission , Bites and Stings/complications , Wound Infection/microbiology , Animals , Antibiotic Prophylaxis , Bacteria, Aerobic/isolation & purification , Bacteria, Anaerobic/isolation & purification , Bacterial Infections/microbiology , Bacterial Infections/prevention & control , Bites and Stings/microbiology , Dogs , Humans , Prognosis , Risk Factors , Wound Infection/prevention & control
14.
J Hosp Infect ; 36(2): 117-22, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9211158

ABSTRACT

Cystic fibrosis (CF) patients often suffer from Pseudomonas aeruginosa lung infection yet the source of this organism is not known. In order to determine whether CF patients might be contaminated with P. aeruginosa from dental equipment, a total of 103 water samples from 25 dental sessions in Frederiksberg Municipal Oral Health Care Service were examined. Three samples (2.9%) were positive for P. aeruginosa. Three hundred and twenty-seven water samples from 82 dental sessions from various other Municipal Oral Health Services in Denmark, attended by CF patients, were also examined. Eighteen of 327 samples (5.5%) from nine sessions (11%) were positive for P. aeruginosa. In one case, genotypically identical (RFLP, pulsed-field gel electrophoresis) P. aeruginosa strains were found both in water from the dental equipment and in the CF patients sputum. This indicates a small risk for acquiring P. aeruginosa from dental sessions, which is however equal to the yearly 'natural background' incidence (1-2%) of acquisition of P. aeruginosa in our CF centre.


Subject(s)
Cystic Fibrosis/complications , Dental Equipment/adverse effects , Equipment Contamination , Infection Control, Dental , Pseudomonas Infections/epidemiology , Case-Control Studies , Denmark/epidemiology , Humans , Pseudomonas Infections/prevention & control , Sputum/microbiology , Water Microbiology
16.
Lancet ; 349(9046): 167-9, 1997 Jan 18.
Article in English | MEDLINE | ID: mdl-9111541

ABSTRACT

BACKGROUND: Staphylococcus epidermidis develops resistance to ciprofloxacin rapidly. That this antibiotic is excreted in apocrine and eccrine sweat of healthy individuals might be the reason for the development of such resistance. We assessed whether S epidermidis isolated from the axilla and nasal flora of healthy people could develop resistance to ciprofloxacin after a 1-week course of this antibiotic. METHODS: The concentration of ciprofloxacin in sweat was measured in seven volunteers after oral administration of 750 mg ciprofloxacin twice daily for 7 days, and the development of resistance in S epidermidis from axilla and nostrils was monitored during and 2 months after the treatment. Genotyping of S epidermidis was done by restriction fragment length polymorphism. FINDINGS: The mean concentration of ciprofloxacin in sweat increased during the 7 days of treatment-from 2.2 micrograms/mL 2.5 h after the first tablet to 2.5 micrograms/mL after the fifth tablet, and 5.5 micrograms/mL after the 13th tablet. All persons harboured susceptible S epidermidis (minimal inhibitory concentration [MIC] 0.25 microgram/mL) in axilla and nostrils before treatment. Four resistant strains were detected, two intermediate-level (MIC 4-12 micrograms/mL) and two high-level (MIC > 32 micrograms/mL). Three of these strains were found in all the participants, and a ciprofloxacin-sensitive variant of one of the high-level resistant strains was also found before the start of the treatment. The high-level resistant strains were also resistant to methicillin, erythromycin, gentamicin, sulphonamide, and trimethoprim. A mean of 2.7 days after the start of the treatment, development of ciprofloxacin resistance was detected in S epidermidis from the axilla of all persons, compared with 11 days for the appearance of resistant S epidermidis in nostrils. The resistant strains persisted for an average of 37 and 39 days in axilla and nostrils, respectively, after the end of the treatment. INTERPRETATION: The rapid development of resistance to ciprofloxacin due to excretion of this drug into the sweat might be involved in the development of multiresistant S epidermidis and possibly other skin bacteria in hospitals and in communities with high use of ciprofloxacin or related drugs.


Subject(s)
Anti-Infective Agents/metabolism , Ciprofloxacin/metabolism , Staphylococcus epidermidis/drug effects , Sweat/chemistry , Administration, Oral , Adult , Anti-Infective Agents/analysis , Anti-Infective Agents/pharmacology , Ciprofloxacin/analysis , Ciprofloxacin/pharmacology , Drug Resistance, Microbial , Drug Resistance, Multiple , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Staphylococcus epidermidis/isolation & purification
17.
APMIS ; 103(12): 869-77, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8562027

ABSTRACT

To study the structure and function of the Legionella flagellum, we screened a genomic L. micdadei library in Escherichia coli for expression of the flagellin (Fla) subunit. One recombinant clone, JM105 (pHI5588), producing a truncated Fla protein of 40.5 kDa was identified. The plasmid pHI5588 carried a L. micdadei DNA insert of 5 kb, containing ca 95% of the fla gene. The complete DNA sequence of the L. micdadei fla gene was obtained by combining sequence data from pHI5588 with results using a polymerase chain reaction-based system for genome walking (vectorette PCR). The L. micdadei fla gene shared a high degree of homology with other flagellin genes in the amino- and carboxy termini, whereas the central region was found to be nonconserved. The fla sequence will facilitate the cloning of Fla proteins from other Legionella species and the study of flagella in the pathogenesis of Legionnaires' disease.


Subject(s)
Escherichia coli/genetics , Flagellin/genetics , Legionella/metabolism , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Bacterial , Flagellin/biosynthesis , Flagellin/isolation & purification , Legionella/genetics , Molecular Sequence Data
18.
Infect Immun ; 63(8): 2840-5, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7622203

ABSTRACT

The pathogenesis of Legionella micdadei is dependent upon its ability to infect alveolar phagocytes. To better understand the basis of intracellular infection by this organism, we examined the importance of its Mip surface protein. In Legionella pneumophila, Mip promotes infection of both human macrophages and freshwater protozoa. Southern hybridization and immunoblot analyses demonstrated that mip sequences were present and expressed within a panel of virulent L. micdadei strains. Using allelic exchange mutagenesis, we then constructed an L. micdadei strain that completely and specifically lacked Mip. Although unimpaired in its ability to grow in bacteriologic media, this Mip mutant was defective in its capacity to infect U937 cells, a human macrophage-like cell line. Most significantly, the Mip- organism displayed a 24-fold reduction in survivability immediately after its entry into the phagocyte. Similarly, the mutant was less able to parasitize Hartmannella amoebae. Taken together, these data argue that Mip specifically potentiates intracellular growth by L. micdadei.


Subject(s)
Bacterial Proteins/genetics , Immunophilins , Legionella/genetics , Membrane Proteins/genetics , Peptidylprolyl Isomerase , Animals , Cell Line , Cytopathogenic Effect, Viral , DNA, Bacterial/genetics , Genes, Bacterial/genetics , Hartmannella/microbiology , Legionella/growth & development , Legionella/pathogenicity , Macrophages/microbiology , Mutagenesis
20.
J Clin Microbiol ; 33(5): 1399-401, 1995 May.
Article in English | MEDLINE | ID: mdl-7615767

ABSTRACT

The purpose of this study was to isolate streptococcal strains from the oral cavities of streptococcal endocarditis patients and compare these strains biochemically and genetically with the corresponding streptococcal blood isolates. Total identity was observed between the blood and oral cavity isolates from the two patients studied.


Subject(s)
Endocarditis, Bacterial/microbiology , Streptococcal Infections/microbiology , Streptococcus/isolation & purification , Aged , Bacteremia/microbiology , Bacterial Typing Techniques , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Dental Plaque/microbiology , Female , Humans , Male , Mouth/microbiology , Saliva/microbiology , Species Specificity , Streptococcus/classification , Streptococcus/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...